Evaluating and managing 'Triple Negative' MPN

preview_player
Показать описание

In this presentation from the Great Debates & Updates in Hematologic Malignancies 2018 conference, Dr. Ruben A. Mesa discusses challenges in the evaluation and management of 'triple negative' myeloproliferative neoplasms (MPN).

© 2018 Imedex, LLC.
  1. HMP Education
  2. Imedex
  3. Continuing Medical Education
  4. CME
  5. Accreditation
  6. Nurse
Рекомендации по теме
Evaluating and managing 0:17:46

Evaluating and managing 'Triple Negative' MPN

How to Treat 0:18:38

How to Treat Triple Negative Breast Cancer | Dr. Ruth O'Regan Chair & Dr. Anna Weiss

Evaluating and Managing 0:05:45

Evaluating and Managing Comorbidities in Early Breast Cancer

New Frontiers in 0:18:29

New Frontiers in Triple Negative Breast Cancer

Navigating the Management 0:38:56

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy Considerations

Novel Therapeutics for 0:31:21

Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets

Residual tumor treatment 0:01:48

Residual tumor treatment in mutant BRCA-1 triple-negative breast cancer

Hormonal Positive Breast 0:00:50

Hormonal Positive Breast Cancer: Detection, Treatment & Risk Assessment

Reflux Is Everywhere: 0:51:21

Reflux Is Everywhere: A Primary Care Guide to Managing Gastroesophageal Reflux Disease

Stage 4 Breast 0:59:57

Stage 4 Breast Cancer - Part 4/4 - 'Treatment of stage 4, triple-negative breast cancers'

Treatment Options for 0:27:45

Treatment Options for Triple-Negative Breast Cancer Prof. Peter Schmid

Meet The Professor: 1:03:18

Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — ......

Treatment and Issues 0:50:33

Treatment and Issues For Triple Negative Breast Cancer-May 14, 2020

Optimising recovery and 0:47:28

Optimising recovery and resilience following Triple Negative Breast Cancer treatment.

Triple-Negative Breast Cancer: 0:22:26

Triple-Negative Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019

Expert Perspectives in 0:13:10

Expert Perspectives in the Management of Triple-Negative Breast Cancer With Sara Tolaney, MD, MPH

Impact of Social 0:10:30

Impact of Social Determinants on Triple-Negative Breast Cancer

Dr. Overmoyer on 0:01:17

Dr. Overmoyer on Inflammatory Triple-Negative Breast Cancer

Pathologic Complete Response 0:00:51

Pathologic Complete Response vs. Partial Response

Expanding the Benefits 1:39:18

Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in Triple-Negative Breast Cancer

Dr. Adams on 0:01:49

Dr. Adams on Combinatorial Approaches in Triple-Negative Breast Cancer

Metastatic Triple-Negative Breast 0:28:25

Metastatic Triple-Negative Breast Cancer Ongoing Trials

Harnessing the Immune 1:04:28

Harnessing the Immune System in the Treatment of Triple-Negative Breast Cancer

Triple-Negative Breast Cancer 0:02:37

Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening - Mayo Clinic